Table 3 The expression of EGFR in TNBC and non-TNBC patients.

From: EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Group

No.

EGFR expression

Negative, n (%)

Positive, n (%)

TNBC

70

15 (21.4%)

55 (78.6%)*

non-TNBC

370

206 (55.7%)

164 (44.3%)

  1. Note: *P < 0.0001.
Back to article page